# Transplantation of Myoblasts to Duchenne Muscular Dystrophy (DMD) Patients

> **NCT02196467** · PHASE1,PHASE2 · UNKNOWN · sponsor: **CHU de Quebec-Universite Laval** · enrollment: 10 (estimated)

## Conditions studied

- Duchenne Muscular Dystrophy

## Interventions

- **BIOLOGICAL:** Myoblast transplantation
- **PROCEDURE:** Saline injection

## Key facts

- **NCT ID:** NCT02196467
- **Lead sponsor:** CHU de Quebec-Universite Laval
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-05
- **Primary completion:** 2024-01
- **Final completion:** 2024-01
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2021-01-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02196467

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02196467, "Transplantation of Myoblasts to Duchenne Muscular Dystrophy (DMD) Patients". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02196467. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*